“At the beginning of the pandemic, there were understandably few tests available for detecting coronavirus infections. But the federal government made the situation much worse by screwing up the development and deployment of testing. The Centers for Disease Control and Prevention botched its own COVID-19 test while the Food and Drug Administration (FDA) blocked the development of alternatives by private companies and universities. Months later, the United States still does not have enough tests.
The good news is that the FDA has since approved more than a couple hundred COVID-19 tests. But these tests are not available on the scale needed to stem the tide of infections by enabling Americans to test themselves, warn friends and family if they test positive, and then voluntarily isolate themselves to prevent the further transmission of the disease.”
…
“Operation Warp Speed was successful at scaling up vaccine production in part because the federal government issued around $18 billion in contracts to their makers. Had the government similarly prioritized COVID-19 testing, the country would not now be piddling around with just 1.5 million tests per day. The Trump administration contracted in late August with Abbott Laboratories to purchase 150 million of its point-of-care BinaxNOW COVID-19 tests for $750 million. The tests, which take about 15 minutes to provide a result, began shipping to state public health agencies at the end of September.
That’s a start, but much more testing needs to be done. Instead of using tests primarily to diagnose COVID-19 cases, they should be used as part of disease surveillance approach in which every American can test themselves frequently.”